CTRI/2012/05/002665招募中未知
AN INVESTIGATOR INITIATED, MULTI-CENTRIC, RETROSPECTIVE, OBSERVATIONAL STUDY TO EVALUATE THE INCIDENCE OF EGFR MUTATIONS IN ADULT INDIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Dr Senthil Rajappa0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Subjects with non-small cell lung Cancer.
- •2.Subjects of Physicians who are willing to share their subjectsâ?? data for this study.
- •3.Ethics Committeeâ??s permission to conduct the analysis on a retrospective manner without the physical consent of the subjects who have contributed to the existing data from their respective institutions
排除标准
- 未提供
研究者
相似试验
已完成
不适用
PROSPECTIVE, SINGLE ARMSTUDY TO DETERMINE THE SAFETY AND EFFICACY OF TOPICAL DICLOFENAC SODIUM GEL WITH NANOTECHNOLOGY IN SUBJECTSWITH OSTEOARTHRITIS OF KNEECTRI/2015/10/006269Mrs Nagalakshmi AnandaPadmanabhan50
进行中（未招募）
1 期
A study to test the effectiveness of bimekizumab as a treatment for rheumatoid arthritis, to look for unwanted side effects and to measure how the drug is distributed, modified and cleared from the body.RHEUMATOID ARTHRITISMedDRA version: 19.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-000393-37-BGCB Biopharma Sprl60
进行中（未招募）
1 期
A study to test the effectiveness of bimekizumab as a treatment for ulcerative colitis to look for unwanted side effects and to measure how the drug is distributed, modified and cleared from the body.SEVERE ACTIVE ULCERATIVE COLITISMedDRA version: 20.0Level: SOCClassification code 10017947Term: Gastrointestinal disordersSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2016-000420-26-PLCB Biopharma SPR60
进行中（未招募）
1 期
A study to test the effectiveness of bimekizumab as a treatment for ulcerative colitis to look for unwanted side effects and to measure how the drug is distributed, modified and cleared from the body.EUCTR2016-000420-26-BGCB Biopharma SPR60
进行中（未招募）
1 期
A study to test the effectiveness of bimekizumab as a treatment for ulcerative colitis to look for unwanted side effects and to measure how the drug is distributed, modified and cleared from the body.EUCTR2016-000420-26-CZCB Biopharma SPR60